NCT07335393Not yet recruiting
Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer
Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer (CARE-VR4PC)
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
1. To assess the cognitive function of patients with cancer by leveraging a validated virtual reality (VR)-based cognitive assessment tool. 2. To evaluate the efficacy of VR-based cognitive rehabilitation therapy (VR-CRT) compared to a control group in improving cognitive functions in cancer patients. Hypothesis Cancer patients with cancer-related cognitive impairment who receive the VR-CRT program will demonstrate significantly greater improvement in cognitive functions, as measured by the validated VR cognition assessment tool, compared to those who receive standard care, both immediately post-intervention and at 3-month follow-up.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 30 Dec 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- JING MINGXUE
- Diseases
- Childhood cancers
- NCT number
- NCT07335393
What you commit to
- Study type: Interventional
- Planned participants: 64
- From 1 Jan 2026 to the primary completion date, 31 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe visual or auditory impairments, motion sickness, or conditions interfering with VR use.
Who the study is looking for
- (1) Cancer (both Solid and haematological) patients with documented cognitive impairments. (2) No history of neurological disorders. (3) Ability to use VR technology.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.